Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 02 Apr 2024

Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study

in Drugs Outcomes Research and Policies

Abdulaziz Alsalem
Mohammed M. Alsultan
Faisal Alqarni
Abdullah Almangour
Lolwa Alsharekh
Saleem Alenazi
Saleh Alzahrani
Raghad A. Almanqour
Abdullah Alazmi
Abdullah Alzahrani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1366439

2,464 views
1 citation

Original Research

Published on 02 Apr 2024

Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in Switzerland

in Drugs Outcomes Research and Policies

Claire Coumau
Frederic Gaspar
Jean Terrier
Angela Schulthess-Lisibach
Monika Lutters
Marie-Annick Le Pogam
Chantal Csajka

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1332147

3,026 views
5 citations

Original Research

Published on 28 Mar 2024

Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States

in Drugs Outcomes Research and Policies

Gengwei Huo
Ying Song
Wenjie Liu
Xuchen Cao
Peng Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1300183

3,705 views
2 citations

Review

Published on 28 Mar 2024

Dose reduction of biologics in patients with plaque psoriasis: a review

in Drugs Outcomes Research and Policies

C. A. M. van Riel
C. A. J. Michielsens
M. E. van Muijen
L. S. van der Schoot
J. M. P. A. van den Reek
E. M. G. J. de Jong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369805

4,504 views
7 citations

Clinical Trial

Published on 28 Mar 2024

Effectiveness of pharmacist-led medication reconciliation on medication errors at hospital discharge and healthcare utilization in the next 30 days: a pragmatic clinical trial

in Drugs Outcomes Research and Policies

Maja Jošt
Mojca Kerec Kos
Mitja Kos
Lea Knez

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377781

7,185 views
6 citations

Original Research

Published on 27 Mar 2024

Patient experience of medication administration and development of a Patient Experience and Preference Questionnaire (PEPQ) for patients with advanced or metastatic cancer

in Drugs Outcomes Research and Policies

Anne Skalicky
Bryan Bennett
Judith Raimbourg
Sara Lonardi
Julia Correll
Iwona Lugowska
Matthew Dixon
Nashmel Sargalo
Mona L. Martin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1310546

3,277 views
2 citations

Original Research

Published on 26 Mar 2024

Cost-effectiveness of immune checkpoint inhibitors in treating metastatic urothelial cancer

in Drugs Outcomes Research and Policies

Li-Yu Yang
Jian-Ri Li
Chuan-Shu Chen
Chen-Li Cheng
Sheng-Chun Hung
Kun-Yuan Chiu
Cheng-Kuang Yang
Chiann-Yi Hsu
Shian-Shiang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1281654

2,325 views
1 citation

Original Research

Published on 19 Mar 2024

Dapagliflozin versus sacubitril–valsartan for heart failure with mildly reduced or preserved ejection fraction

in Drugs Outcomes Research and Policies

Ronen Arbel
Abed N. Azab
Mansi Oberoi
Enis Aboalhasan
Artyom Star
Khaled Elhaj
Fouad Khalil
Hilmi Alnsasra

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1357673

3,666 views
1 citation

Original Research

Published on 18 Mar 2024

Assessment of the implementation of accelerated drug marketing registration procedures for antineoplastic and immunomodulating agents in China: based on 2016–2022 review data

in Drugs Outcomes Research and Policies

Yipeng Lan
Xiaofeng Lin
Jialin Yu
Li Wang
Lihua Sun
Zhe Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1345672

2,208 views
2 citations

Original Research

Published on 18 Mar 2024

Examining the safety of mirabegron: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) database

in Drugs Outcomes Research and Policies

Junwei Wang
Aiwei Zhang
Miaoyong Ye
Cunming Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376535

6,940 views
6 citations

Original Research

Published on 13 Mar 2024

Impact of treatment adherence and inhalation technique on asthma outcomes of pediatric patients: a longitudinal study

in Drugs Outcomes Research and Policies

Catalina Lizano-Barrantes
Olatz Garin
Karina Mayoral
Alexandra L. Dima
Angels Pont
María Araceli Caballero-Rabasco
Manuel Praena-Crespo
Laura Valdesoiro-Navarrete
María Teresa Guerra
Alberto Bercedo-Sanz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1340255

3,782 views
2 citations

Original Research

Published on 12 Mar 2024

The Prescription trends and dosing appropriateness analysis of novel oral anticoagulants in ischemic stroke patients: a retrospective study of 9 cities in China

in Drugs Outcomes Research and Policies

Mingfen Wu
Hailun Jiang
Kefu Yu
Zhigang Zhao
Bin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1304139

1,808 views
1 citation

Original Research

Published on 12 Mar 2024

A real-world disproportionality analysis of Everolimus: data mining of the public version of FDA adverse event reporting system

in Drugs Outcomes Research and Policies

Bin Zhao
Yumei Fu
Shichao Cui
Xiangning Chen
Shu Liu
Lan Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1333662

4,238 views
21 citations

Original Research

Published on 11 Mar 2024

Pharmacological treatments and medication-related problems in nursing homes in Catalonia: a multidisciplinary approach

in Drugs Outcomes Research and Policies

Emilie Anderssen-Nordahl
Margarita Sánchez-Arcilla Rosanas
Montserrat Bosch Ferrer
Mònica Sabaté Gallego
Eladio Fernández-Liz
Antonio San-José
Maria Estrella Barceló-Colomer

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1320490

2,809 views
2 citations

Systematic Review

Published on 08 Mar 2024

Efficacy and safety of levosimendan in patients with sepsis: a systematic review and network meta-analysis

in Drugs Outcomes Research and Policies

Ruimin Tan
He Guo
Zinan Yang
Huihui Yang
Qinghao Li
Qiong Zhu
Quansheng Du

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1358735

4,163 views
3 citations

Original Research

Published on 08 Mar 2024

Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries

in Drugs Outcomes Research and Policies

Szczepan Jakubowski
Pawel Kawalec
Przemyslaw Holko
Iwona Kowalska-Bobko
Maria Kamusheva
Guenka Petrova
Pero Draganić
Leos Fuksa
Agnes Männik
Fanni Ispán

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369178

3,622 views
3 citations